Literature DB >> 10076561

Development of androgen-independent carcinomas from androgen-dependent preneoplastic lesions in the male accessory sex organs of rats treated with 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.

S Iwasaki1, K Kato, T Mori, S Takahashi, M Futakuchi, T Shirai.   

Abstract

Two kinds of cancer can be induced in rat male accessory sex organs, one a non-invasive carcinoma arising in the ventral lobe and the other an invasive lesion which develops in the dorsolateral and anterior lobe as well as the seminal vesicles. In the present study, one group of male rats were given biweekly s.c. injections of 3,2'-dimethyl-4-aminobiphenyl (DMAB) for 20 weeks for induction of non-invasive carcinomas and the other group received DMAB with 40-week testosterone propionate for induction of invasive carcinomas. Half of the animals in each group were then subjected to bilateral orchiectomy at week 41 to remove testicular androgen, in order to examine the androgen dependence of both types of carcinomas as well as precancerous lesions. Animals were killed at weeks 41, 46 and 60. All parts of the prostate complex showed involution and significant weight reduction after castration, with a complete disappearance of atypical hyperplasias and carcinomas of the ventral prostate. However, in spite of suppression of development of atypical hyperplasias in the anterior prostate and seminal vesicles, the incidence of invasive carcinomas was not changed. Normal epithelial cells and atypical hyperplasias of all parts of the prostate and seminal vesicles and carcinomas of the ventral prostate were immunohistochemically positive for nuclear androgen receptor, while invasive carcinomas that developed in either castrated or non-castrated animals were negative. These findings suggest that in the ventral prostate, both precancerous and cancerous lesions are androgen-dependent, but in the anterior and seminal vesicles, cancerous lesions (invasive carcinomas) are androgen-independent while precancerous lesions are hormone-dependent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076561      PMCID: PMC5925988          DOI: 10.1111/j.1349-7006.1999.tb00661.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  26 in total

1.  Focal microsatellite mutations in relatives with prostatic adenocarcinoma.

Authors:  A H Wille; R B Terrell; J C Cheville; V C Sheffield; M B Cohen
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

2.  Immunohistochemically demonstrated androgen receptor expression in the rat prostate during carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl with or without testosterone.

Authors:  T Shirai; S Takahashi; T Mori; K Imaida; M Futakuchi; S H Ye; G S Prins; N Ito
Journal:  Urol Oncol       Date:  1995 Nov-Dec       Impact factor: 3.498

3.  Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

Authors:  P C Walsh; J D Madden; M J Harrod; J L Goldstein; P C MacDonald; J D Wilson
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

Review 4.  Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.

Authors:  P Koivisto; T Visakorpi; O P Kallioniemi
Journal:  Scand J Clin Lab Invest Suppl       Date:  1996

5.  Androgen receptor localization in different cell types of the adult rat prostate.

Authors:  G S Prins; L Birch; G L Greene
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

6.  Induction of prostate carcinoma in situ at high incidence in F344 rats by a combination of 3,2'-dimethyl-4-aminobiphenyl and ethinyl estradiol.

Authors:  T Shirai; S Fukushima; E Ikawa; Y Tagawa; N Ito
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

7.  Duration dependent induction of invasive prostatic carcinomas with pharmacological dose of testosterone propionate in rats pretreated with 3,2'-dimethyl-4-aminobiphenyl and development of androgen-independent carcinomas after castration.

Authors:  T Shirai; M Sano; K Imaida; S Takahashi; T Mori; N Ito
Journal:  Cancer Lett       Date:  1994-08-15       Impact factor: 8.679

8.  Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.

Authors:  M C Bosland; H Ford; L Horton
Journal:  Carcinogenesis       Date:  1995-06       Impact factor: 4.944

9.  Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2'-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats.

Authors:  H Nakanishi; S Takeuchi; K Kato; S Shimizu; K Kobayashi; M Tatematsu; T Shirai
Journal:  Jpn J Cancer Res       Date:  1996-12

10.  Direct effects of testosterone, dihydrotestosterone and estrogen on 3,2'-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis in castrated F344 rats.

Authors:  T Mori; L Cui; K Kato; S Takahashi; K Imaida; S Iwasaki; N Ito; T Shirai
Journal:  Jpn J Cancer Res       Date:  1996-06
View more
  1 in total

1.  The MNU Plus Testosterone Rat Model of Prostate Carcinogenesis.

Authors:  Maarten C Bosland; Michael J Schlicht; Lori Horton; David L McCormick
Journal:  Toxicol Pathol       Date:  2022-05-19       Impact factor: 1.930

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.